Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on April 14, 2025
Sterling Lexicon's Redesigned Website Enhances User Experience, Showcases Talent Mobility Expertise
EIN Presswire
·
April 14, 2025
New features emphasize flexible solutions to meet changing workforce mobility priorities JACKSONVILLE, FL, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Sterling Lexicon, a global leader in workforce mobility solutions, is proud to unveil its …
BioSyent to Attend Planet MicroCap Showcase
GlobeNewswire
·
April 14, 2025
MISSISSAUGA, Ontario, April 14, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be attending the Planet MicroCap Showcase: VEGAS 2025 investor conference in Las Vegas, Nevada from April 22nd to April …
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 14, 2025
WALTHAM, Mass., April 14, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases, today announced that it …
Voting Rights and Shares Capital of the Company
GlobeNewswire
·
April 14, 2025
In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, April 14, 2025 (GLOBE NEWSWIRE) -- Market: Euronext Paris / Nasdaq …
BioStem Technologies Reports Record Preliminary Fourth-Quarter Net Revenue of $102.9 Million and Preliminary Full-Year 2024 Revenue of $301.8 Million
GlobeNewswire
·
April 14, 2025
Company reports record preliminary fourth quarter net revenue of $102.9 Million, contributing to a total of $301.8 Million in revenue for 2024 Achieves preliminary GAAP net income of $15.5 million, or $0.94 per share, marking the fourth consecutive quarter …
Verano Announces Promotion and Appointment of Richard Tarapchak as Chief Financial Officer
GlobeNewswire
·
April 14, 2025
Tarapchak brings more than 30 years of accounting and finance expertise to the role CHICAGO, April 14, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today …
Can-Fite to Generate $685M in Projected Future Revenues from its Partnerships
GlobeNewswire
·
April 14, 2025
Ramat Gan, Israel, April 14, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs for oncological and inflammatory diseases, today announced …
NeOnc Technologies Holdings, Inc. Expects Full Enrollment in Promising Phase 2a Trial of NEO100-01 for Malignant Gliomas in September
GlobeNewswire
·
April 14, 2025
-- Trial Read-Out Data Expected in Early 2026 -- CALABASAS, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a clinical-stage biopharmaceutical company focused on innovative treatments for central nervous system …
Celularity Welcomes CMS Action on Medicare Local Coverage Determination for Skin Substitutes Products
GlobeNewswire
·
April 14, 2025
FLORHAM PARK, N.J., April 14, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative and cellular medicine company, welcomes action by the Centers for Medicare …
Lachine Hospital Foundation Gala raises $406,500 to support the modernization of Lachine Hospital
GlobeNewswire
·
April 14, 2025
The Lachine Hospital Foundation’s signature Gala raised an incredible $406,500 to support the Dream Big: Lachine Hospital campaign, a successful collaboration between the Lachine Hospital Foundation and the MUHC Foundation. The $5 million campaign, is …
SBC Medical Group Holdings, Inc. Purchases 5 BTC
GlobeNewswire
·
April 14, 2025
IRVINE,Calif., April 14, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings (Headquarters: California, USA; CEO: Yoshiyuki Aikawa) hereby announces that, based on the announcement of a decision to purchase Bitcoin (BTC) disclosed on February 12, 2025, it …
Relmada Therapeutics To Present NDV-01 Data at AUA2025
GlobeNewswire
·
April 14, 2025
CORAL GABLES, Fla., April 14, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada”, “the Company”), a clinical-stage biotechnology company, today announced the presentation of an abstract at the American Urology Association (AUA2025 …
XOMA Royalty Completes Sale of Kinnate Pipeline Assets
GlobeNewswire
·
April 14, 2025
XOMA Royalty sold the remaining Kinnate pipeline assets for a total of up to $270 million in upfront and milestone payments, plus royalties on commercial sales at rates ranging from low single digits to mid-teens Holders of Kinnate Contingent Value Rights …
Avicanna Reports Full Year 2024 Audited Financial Statement
GlobeNewswire
·
April 14, 2025
2024 Revenue of $25.5M, a 52% increase from 2023 Consolidated Gross Margins of 51%, Gross Profits of $12.9M, a 94% increase from 2023 TORONTO, April 14, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: …
Castle Biosciences to Release First Quarter 2025 Financial Results and Host Conference Call on Monday, May 5, 2025
GlobeNewswire
·
April 14, 2025
FRIENDSWOOD, Texas, April 14, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for the first quarter …
Skye Bioscience to Conduct Meetings at Piper Sandler Conference
GlobeNewswire
·
April 14, 2025
SAN DIEGO, April 14, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced that its …
Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US
GlobeNewswire
·
April 14, 2025
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Company aims to accelerate access to much-needed biosimilar to reference medicine Enbrel®* for US patients with disabling inflammatory diseases Despite FDA approval nearly a decade …